Navigation Links
Chembio Reports 3rd Quarter 2011 Results
Date:11/3/2011

ments regarding the intent, belief or current expectations of the Company and its management. Such statements are estimates only. They reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to Chembio's ability to obtain additional financing and to obtain regulatory approvals in a timely manner, as well as the demand for Chembio's products. Chembio undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in Chembio's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact Chembio's success are more fully disclosed in Chembio's most recent public filings with the U.S. Securities and Exchange Commission.

Contacts:
Company Contact:
Susan Norcott 631-924-1135 x125 or
snorcott@chembio.com

Investor & Public Relations
The Investor Relations Group
212-825-3210
Adam S. Holdsworth
aholdsworth@investorrelationsgroup.com

(Tables to follow)Chembio Diagnostics, Inc.Summary of Results of Operations(Unaudited)For the three months endedFor the nine months endedSeptember 30, 2011September 30, 2010September 30, 2011September 30, 2010 Net product sales $
5,526,883$
3,786,572$
,516,325$
8,337,133 License and royalty revenue 25,00061,789125,322400,758 R&D, milestone and grant revenue 369,904656,6421,529,9722,299,970 TOTAL REVENUES $
5,921,787$
4,505,003$
3,171,619$
,037,861 GROSS MARGIN $
2,670,733$

'/>"/>

SOURCE Chembio Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Chembio to Host Conference Call to Discuss 3rd Quarter 2011 Financial Results
2. Chembio Diagnostics CFO Richard J. Larkin Among the Recipients of "2011 CFO of the Year" Award from Long Island Business News
3. NxStage Reports Record Third Quarter 2011 Financial Results and Raises Revenue Guidance For 2011
4. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. CVS Caremark Reports Third Quarter Results
6. Onyx Pharmaceuticals Reports Third Quarter 2011 Financial Results
7. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2011 Financial Results and Provides Pipeline Update
8. Nektar Therapeutics Reports Third Quarter 2011 Financial Results
9. Par Pharmaceutical Companies Reports Third Quarter 2011 Results
10. Luminex Corporation Reports Third Quarter 2011 Results
11. Anthera Pharmaceuticals Reports 2011 Third Quarter Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Registreer nu via  http://bit.ly/ag8Sypm14de ... Februar sind alle akkreditierten pharmazeutischen Patientenversorgungsakten-Firmen (PMR) ... PROGRAMM ™ 2015 in Amsterdam ... Tagung soll dazu beitragen, der Aegate PMR ... profitablen Unternehmensdienstleistungen, die für Apotheken und die ...
(Date:12/15/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Cardiac Guidewires - Global ... Global Guidewires sector is projected to reach US$1.6 ... accounts for nearly 35% (2015) of the global ... 25% (2018). Asia-Pacific is the ...
(Date:12/15/2014)... BRIDGEWATER, N.J. , Dec. 15, 2014 /PRNewswire/ ... (EURONEXT: SAN and NYSE: SNY) are collaborating with nationally-recognized ... Cholesterol Counts , an awareness program that will gauge ... the risks associated with high LDL-C (bad cholesterol).  American ... to take a brief poll and answer a ...
Breaking Medicine Technology:Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6
... MISSISSAUGA, Ontario, Dec. 16, 2011  Valeant Pharmaceuticals International, ... today announced successful results from two large international ... {efinaconazole (IDP-108)} product for the treatment of mild ... the studies, the investigational drug product was found ...
... 16, 2011  For the fifth time in the past six ... nation,s best provider of patient flow automation , according ... KLAS is an independent market research company which ... clinicians from over 4,500 hospitals and 2,500 clinics, who have ...
Cached Medicine Technology:Valeant Announces Successful Results From Phase III Onychomycosis Trials 2TeleTracking Again Voted 2011 "Best in KLAS" Category Leader in Patient Flow 2
(Date:12/17/2014)... No matter how far modern medicine advances, ... head louse parasite—a common childhood malady and a source ... six and twelve million individuals will suffer an infestation. ... company comes to the rescue, providing an all-natural treatment ... track record of customer service, and effectiveness in getting ...
(Date:12/17/2014)... Alan Mozes HealthDay Reporter , ... of infectious diseases, one worrisome phenomenon is when an illness ... process -- known as zoonosis -- is not uncommon and ... that an animal-borne disease might make inroads into the human ... development -- and the culprits in this case were guinea ...
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... holiday party season fast approaching, a new study reveals that ... arrests have fewer drunk drivers on their roads. The ... vigilantly are better able to deter inebriated revelers from getting ... new laws are being passed regarding drinking and driving," said ...
(Date:12/15/2014)... Cancer researchers have just published an important new ... malignant pleural mesothelioma. Surviving Mesothelioma has just posted an ... here to read it now. , Doctors at ... New York’s Langone Medical Center performed complete genetic analyses ... an effort to pinpoint the genes that are most ...
(Date:12/15/2014)... 2014 SIMpalm, a leading mobile ... for iPhone for its client, which allows users to ... company, specialized in finding the right wine. At ... uses combined sensory, chemistry and wine information. All this ... “wine fingerprint.” Those wines that are close counterparts to ...
Breaking Medicine News(10 mins):Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2
... of Medicine have found that children living near the ... nearly 20 times as high as the typical lead ... published in the current issue of Environmental Health ... Professor of Preventive Medicine and Pediatrics and Co-Director of ...
... calls The Curious Case of Benjamin Button to mind. ... adult cells to revert to an embryonic stem cell-like state, ... with the potential to treat heart attacks or diseases such ... only one percent of cells are successfully being reprogrammed. ...
... ... Total Artificial Heart a Reality , ... Tucson, Ariz. (Vocus) June 29, 2010 -- On July 1, Total Artificial Heart pioneer ... $227 million Sulpizio Family Cardiovascular Center at the University of California, San Diego in La ...
... in Germany is in favor of complete reform of ... are more satisfied. A working group around Prof. Peter ... Health Care (Institut fr Qualitt und Wirtschaftlichkeit im Gesundheitswesen, ... by the Commonwealth Fund in 2005 and 2008 (Dtsch ...
... New Event ... In November 16-17, 2010 , ... Toronto (PRWEB) June 29, 2010 -- Today, SC Magazine announced the ... discuss lessons learned and best practices to help organizations address the burgeoning landscape of security ...
... ... of their latest offering to the Life Sciences, University, and Clinical research labs with ... biology applications. , ... (PRWEB) June 29, 2010 -- Anaerobic Glove Boxes have made a name for ...
Cached Medicine News:Health News:Lead poisoning highly prevalent among school-aged children in Uganda 2Health News:Turning back the cellular clock 2Health News:World Renowned Total Artificial Heart Pioneer Dr. Jack Copeland Joins Faculty at UC San Diego 2Health News:World Renowned Total Artificial Heart Pioneer Dr. Jack Copeland Joins Faculty at UC San Diego 3Health News:SC Magazine Strengthens Commitment to Canadian Information Security with Inaugural SC Congress Canada 2Health News:SC Magazine Strengthens Commitment to Canadian Information Security with Inaugural SC Congress Canada 3Health News:SC Magazine Strengthens Commitment to Canadian Information Security with Inaugural SC Congress Canada 4Health News:Sheldon Manufacturing, Inc. Announces New Ergonomic Bactron Anaerobic Chamber For Microbiology Research 2
... specifically for posteror segment ... fluid from subretinal space. ... atraumatic entry through retinal ... holes. 6mm flexible tip ...
Product designed specifically for posteror segment surgical procedures. Facilitates posterior segment infusion. Flexible tubing 10in (25cm)....
For surgical treatment, repair and irrigation of the nasolacrimal system. Silicone tubing. Length 14in (35cm) ID: .012in (.30mm) OD: .025in (.60mm)...
IOL choppers for positioning intraocular lenses. Blunt tip avoids damage to intraocular lenses. .25mm diameter tip. Angles 45 degrees, 10mm from tip....
Medicine Products: